Karin M. J. Koolen

Diversity-oriented synthesis yields novel multistage antimalarial inhibitors

Nobutaka Kato, Eamon Comer, Tomoyo Sakata‐Kato et al. · Nature · 2016 · 266 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases

Marie Miglianico, Maarten Eldering, Hannah Slater et al. · Proceedings of the National Academy of Sciences · 2018 · 111 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

Antimalarial pantothenamide metabolites target acetyl–coenzyme A biosynthesis in <i>Plasmodium falciparum</i>

Joost Schalkwijk, Erik L. Allman, Patrick A.M. Jansen et al. · Science Translational Medicine · 2019 · 91 citations

Life Sciences, Infectious Diseases, Pharmacology +17

A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes

Martijn Vos, William J. Stone, Karin M. J. Koolen et al. · Scientific Reports · 2015 · 75 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs

Judith M. Bolscher, Karin M. J. Koolen, Geert Jan van Gemert et al. · Journal of Antimicrobial Chemotherapy · 2015 · 57 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +15